PIK3CA and glioblastoma: Considering that both PIK3CA mutations and PTEN loss/mutation are commonly found in GBM, isoform-specific PI3K inhibitors, especially against p110α and p110β, could have prospective roles in the treatment of GBM characterized by these genetic mutations.